{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:55:29Z","timestamp":1789095329140,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suqian Key Research and Development Program","award":["S202017, S202110"],"award-info":[{"award-number":["S202017, S202110"]}]},{"name":"Geriatric Health Scientific Research Project of Jiangsu Province","award":["LK2021059"],"award-info":[{"award-number":["LK2021059"]}]},{"name":"Medical Scientific Research Foundation of Jiangsu Province of China","award":["M2020102"],"award-info":[{"award-number":["M2020102"]}]},{"name":"Open project of the National Traditional Chinese Medicine Clinical Research Base","award":["JD2022SZXZD05, JD2023SZX08"],"award-info":[{"award-number":["JD2022SZXZD05, JD2023SZX08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01900-9","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:26:51Z","timestamp":1742279211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Triglyceride-glucose index is independently associated with fatty pancreas disease in Chinese elderly"],"prefix":"10.1186","volume":"25","author":[{"given":"Weinuo","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"1","key":"1900_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Sig Transduct Target Ther. 2022;7(1):391.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11357-022-00608-1","volume":"45","author":"J Ding","year":"2023","unstructured":"Ding J, Lohman K, Molina A, et al. The association between aging-related monocyte transcriptional networks and comorbidity burden: the Multi-Ethnic study of atherosclerosis (MESA). GeroScience. 2023;45(1):197\u2013207.","journal-title":"GeroScience"},{"issue":"7","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2468-1253(23)00064-X","volume":"8","author":"MS Petrov","year":"2023","unstructured":"Petrov MS. Fatty change of the pancreas: the Pandora\u2019s box of pancreatology. Lancet Gastroenterol Hepatol. 2023;8(7):671\u201382.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1900_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41574-021-00573-3","volume":"18","author":"R Wagner","year":"2022","unstructured":"Wagner R, Eckstein SS, Yamazaki H, et al. Metabolic implications of pancreatic fat accumulation. Nat Rev Endocrinol. 2022;18(1):43\u201354.","journal-title":"Nat Rev Endocrinol"},{"issue":"19","key":"1900_CR5","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.3390\/cancers15194876","volume":"15","author":"M Lipp","year":"2023","unstructured":"Lipp M, Tarj\u00e1n D, Lee J, et al. Fatty pancreas is a risk factor for pancreatic cancer: A systematic review and Meta-Analysis of 2956 patients. Cancers (Basel). 2023;15(19):4876.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.xcrm.2023.101391","volume":"5","author":"H Yamazaki","year":"2024","unstructured":"Yamazaki H, Streicher SA, Wu L, et al. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. Cell Rep Med. 2024;5(2):101391.","journal-title":"Cell Rep Med"},{"key":"1900_CR7","doi-asserted-by":"crossref","unstructured":"Filippatos T D, Alexakis K, Mavrikaki V, et al. Nonalcoholic fatty pancreas disease: role in metabolic syndrome, prediabetes, diabetes and atherosclerosis. Dig Dis Sci. 2022;67(1):26\u201341.","DOI":"10.1007\/s10620-021-06824-7"},{"issue":"3","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.jhepr.2023.100998","volume":"6","author":"AL Mak","year":"2024","unstructured":"Mak AL, Wassenaar N, van Dijk AM, et al. Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease. JHEP Rep. 2024;6(3):100998.","journal-title":"JHEP Rep"},{"issue":"9","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.3390\/nu12092883","volume":"12","author":"J Ko","year":"2020","unstructured":"Ko J, Skudder-Hill L, Cho J, et al. The relationship between abdominal fat phenotypes and insulin resistance in Non-Obese individuals after acute pancreatitis. Nutrients. 2020;12(9):2883.","journal-title":"Nutrients"},{"issue":"4","key":"1900_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ajg.2014.1","volume":"109","author":"VWS Wong","year":"2014","unstructured":"Wong VWS, Wong GLH, Yeung DKW, et al. Fatty pancreas, insulin resistance, and \u03b2-Cell function: A population study using Fat-Water magnetic resonance imaging. Am J Gastroenterol. 2014;109(4):589\u201397.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1900_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/jdi.12665","volume":"8","author":"T Yu","year":"2017","unstructured":"Yu T, Wang C. Impact of non-alcoholic fatty pancreas disease on glucose metabolism. J Diabetes Invest. 2017;8(6):735\u201347.","journal-title":"J Diabetes Invest"},{"issue":"2","key":"1900_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3803\/EnM.2019.34.2.179","volume":"34","author":"SB Lee","year":"2019","unstructured":"Lee SB, Kim MK, Kang S, et al. Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults. Endocrinol Metab. 2019;34(2):179.","journal-title":"Endocrinol Metab"},{"key":"1900_CR13","doi-asserted-by":"crossref","unstructured":"Kitae A, Hashimoto Y, Hamaguchi M et al. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Canadian Journal of Gastroenterology and Hepatology, 2019, 2019: 1\u20137.","DOI":"10.1155\/2019\/5121574"},{"issue":"1","key":"1900_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12944-020-01393-6","volume":"19","author":"W Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, et al. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis. 2020;19(1):218.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1900_CR15","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.diabet.2022.101345","volume":"48","author":"B Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re B, Jaussent A, Macioce V, et al. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes Metab. 2022;48(4):101345.","journal-title":"Diabetes Metab"},{"issue":"1","key":"1900_CR16","doi-asserted-by":"publisher","first-page":"20872","DOI":"10.1038\/s41598-022-24182-w","volume":"12","author":"W Ni","year":"2022","unstructured":"Ni W, Zhang M, Wang X, et al. Age-specific serum Thyrotropin reference range for the diagnosis of subclinical hypothyroidism and its association with lipid profiles in the elderly population. Sci Rep. 2022;12(1):20872.","journal-title":"Sci Rep"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"1216308","DOI":"10.3389\/fendo.2023.1216308","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ni W, Zhang L, et al. Age-specific association between thyroid autoimmunity and hypothyroidism in Chinese adults aged over 65 years: a cross-sectional study. Front Endocrinol. 2023;14:1216308.","journal-title":"Front Endocrinol"},{"key":"1900_CR18","doi-asserted-by":"crossref","unstructured":"Hu X, Zhang L, Zhang M et al. Correlation of subclinical hypothyroidism with sarcopenia and its components in the Chinese older adults. Endocrine, 2023.","DOI":"10.1007\/s12020-023-03654-7"},{"key":"1900_CR19","unstructured":"Fahim NK, Negida A. Sample size calculation Guide - Part 1: how to calculate the sample size based on the prevalence rate. Adv J Emerg Med, 2018(In press)."},{"key":"1900_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2016.12.012","volume":"69","author":"RG Singh","year":"2017","unstructured":"Singh RG, Yoon HD, Wu LM, et al. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. Metabolism. 2017;69:1\u201313.","journal-title":"Metabolism"},{"issue":"6","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD). European association for the study of obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59(6):1121\u201340.","journal-title":"Diabetologia"},{"issue":"1","key":"1900_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan W, Chitturi S, et al. Asia\u2013Pacific working party on Non-alcoholic fatty liver disease guidelines 2017\u2014Part 1: definition, risk factors and assessment. J Gastro Hepatol. 2018;33(1):70\u201385.","journal-title":"J Gastro Hepatol"},{"issue":"3","key":"1900_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.rcl.2019.01.003","volume":"57","author":"RG Barr","year":"2019","unstructured":"Barr RG. Ultrasound of diffuse liver disease including elastography. Radiol Clin North Am. 2019;57(3):549\u201362.","journal-title":"Radiol Clin North Am"},{"issue":"15","key":"1900_CR24","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3748\/wjg.15.1869","volume":"15","author":"JS Lee","year":"2009","unstructured":"Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. WJG. 2009;15(15):1869.","journal-title":"WJG"},{"issue":"12","key":"1900_CR25","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.metabol.2011.04.006","volume":"60","author":"F Abbasi","year":"2011","unstructured":"Abbasi F, Reaven GM. Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides \u00d7 glucose versus triglyceride\/high-density lipoprotein cholesterol. Metabolism. 2011;60(12):1673\u20136.","journal-title":"Metabolism"},{"issue":"1","key":"1900_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-022-01661-7","volume":"21","author":"Z Liu","year":"2022","unstructured":"Liu Z, He H, Dai Y, et al. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis. 2022;21(1):55.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"1900_CR27","first-page":"833","volume":"44","author":"Joint committee issued Chinese guideline for the management of dyslipidemia in adults","year":"2016","unstructured":"Joint committee issued Chinese guideline for the management of dyslipidemia in adults. 2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chin J Cardiol. 2016;44(10):833\u201353.","journal-title":"Chin J Cardiol"},{"issue":"05","key":"1900_CR28","first-page":"321","volume":"23","author":"Chinese Nutrition Society Obesity Prevention and Control Section","year":"2022","unstructured":"Chinese Nutrition Society Obesity Prevention and Control Section. Expert consensus on obesity prevention and treatment in China [J]. Chin Prev Med. 2022;23(05):321\u201339.","journal-title":"Chin Prev Med"},{"issue":"6","key":"1900_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: A systematic analysis of Population-Based studies from 90 countries. Circulation. 2016;134(6):441\u201350.","journal-title":"Circulation"},{"issue":"3","key":"1900_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1148\/radiol.2018170331","volume":"287","author":"CS Hung","year":"2018","unstructured":"Hung CS, Tseng PH, Tu CH, et al. Increased pancreatic echogenicity with US: relationship to glycemic progression and incident diabetes. Radiology. 2018;287(3):853\u201363.","journal-title":"Radiology"},{"issue":"26","key":"1900_CR31","doi-asserted-by":"publisher","first-page":"e11293","DOI":"10.1097\/MD.0000000000011293","volume":"97","author":"S Weng","year":"2018","unstructured":"Weng S, Zhou J, Chen X, et al. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. Medicine. 2018;97(26):e11293.","journal-title":"Medicine"},{"issue":"8","key":"1900_CR32","doi-asserted-by":"publisher","first-page":"e2918","DOI":"10.1002\/dmrr.2918","volume":"33","author":"RG Singh","year":"2017","unstructured":"Singh RG, Yoon HD, Poppitt SD, et al. Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2017;33(8):e2918.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1900_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1475-2840-12-77","volume":"12","author":"WC Wu","year":"2013","unstructured":"Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case\u2013control retrospective study. Cardiovasc Diabetol. 2013;12(1):77.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"1900_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ca.20543","volume":"20","author":"Y Saisho","year":"2007","unstructured":"Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20(8):933\u201342.","journal-title":"Clin Anat"},{"key":"1900_CR35","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, An X, Yang C, et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne). 2023;14:1149239.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"1900_CR36","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the Euglycemic-Hyperinsulinemic clamp. J Clin Endocrinol Metabolism. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1900_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","volume":"20","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, et al. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.","journal-title":"Cardiovasc Diabetol"},{"key":"1900_CR38","doi-asserted-by":"publisher","first-page":"644035","DOI":"10.3389\/fcvm.2021.644035","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang W, Jiang X. Association between Triglyceride-Glucose index and hypertension: A Meta-Analysis. Front Cardiovasc Med. 2021;8:644035.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1900_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","volume":"22","author":"A Khalaji","year":"2023","unstructured":"Khalaji A, Behnoush AH, Khanmohammadi S, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1900_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12933-024-02241-y","volume":"23","author":"JL Yin","year":"2024","unstructured":"Yin JL, Yang J, Song XJ, et al. Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies. Cardiovasc Diabetol. 2024;23(1):177.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1900_CR41","doi-asserted-by":"publisher","first-page":"e081131","DOI":"10.1136\/bmjopen-2023-081131","volume":"14","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Wang H, Han L, et al. Predictive value of anthropometric and biochemical indices in non-alcoholic fatty pancreas disease: a cross-sectional study. BMJ Open. 2024;14(4):e081131.","journal-title":"BMJ Open"},{"issue":"1","key":"1900_CR42","doi-asserted-by":"publisher","first-page":"e000297","DOI":"10.1161\/JAHA.113.000297","volume":"3","author":"C Wang","year":"2014","unstructured":"Wang C, Ou H, Chen M, et al. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. JAHA. 2014;3(1):e000297.","journal-title":"JAHA"},{"issue":"10","key":"1900_CR43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/apt.12963","volume":"40","author":"L Fedchuk","year":"2014","unstructured":"Fedchuk L, Nascimbeni F, Pais R, et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2014;40(10):1209\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1900_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"1900_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2014.11.007","volume":"26","author":"A Uygun","year":"2015","unstructured":"Uygun A, Kadayifci A, Demirci H, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015;26(1):37\u201341.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"1900_CR46","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/oby.2007.110","volume":"16","author":"KE Pinnick","year":"2008","unstructured":"Pinnick KE, Collins SC, Londos C, et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity. 2008;16(3):522\u201330.","journal-title":"Obesity"},{"issue":"3","key":"1900_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41575-021-00551-0","volume":"19","author":"MS Petrov","year":"2022","unstructured":"Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat Rev Gastroenterol Hepatol. 2022;19(3):153\u201368.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"1900_CR48","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/j.orcp.2013.05.004","volume":"7","author":"M Matsuda","year":"2013","unstructured":"Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7(5):e330\u201341.","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"1900_CR49","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2174\/1871530318666180328111302","volume":"18","author":"BS Romana","year":"2018","unstructured":"Romana BS, Chela H, Dailey FE, et al. Non-alcoholic fatty pancreas disease (NAFPD): A silent spectator or the fifth component of metabolic syndrome?? A literature review. Endocr Metab Immune Disord Drug Targets. 2018;18(6):547\u201354.","journal-title":"Endocr Metab Immune Disord Drug Targets"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01900-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:58:32Z","timestamp":1742281112000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01900-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01900-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine (2023-LWKYZ-027). Written informed consent was obtained from parents of the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}